Prescribing pattern of COX-2 inhibitors in patients with a history of allergy to conventional NSAIDs in hospital belong to Thai Redcross Society
Main Article Content
Keywords
NSAIDs allergy, prescribing pattern, Cox-2 inhibitors, conventional NSAIDs
Abstract
Introduction: Non-steroidal anti-inflammatory drugs (NSAIDs) are known to cause allergic reactions, particularly conventional NSAIDs [1,2]. COX-2 inhibitors may be a suitable alternative for patients with a history of conventional NSAID allergies [3]. This study aimed to explore the prescribing rate and pattern of COX-2 inhibitors in patients with a history of conventional NSAID allergies. Method: A retrospective descriptive study was conducted using the computerized drug allergy history database from Queen Savang Vadhana Memorial Hospital (QSMH) between January 1, 2013, and December 31, 2016. Percentage statistics were used for comparison. Results: Among 638 patients, the most common allergy was to ibuprofen (34.95%), and the most frequently prescribed COX-2 inhibitor was etoricoxib (34.48%). The most common type of allergy to conventional NSAIDs was angioedema (42.65%), primarily associated with ibuprofen. Non-serious adverse drug reactions (ADRs) occurred in 90.61% of cases, while serious ADRs (anaphylaxis, acute renal failure, and anaphylactic shock) accounted for 9.39%. Physician staff prescribed COX-2 inhibitors most frequently (63.75%), with the orthopedic surgery unit being the most common prescribing department (48.17%). Conclusion: This study provides insights into the prescribing pattern of COX-2 inhibitors in patients with a history of conventional NSAID allergies. This information is valuable for establishing monitoring plans to ensure optimal medication safety for this patient group.
References
to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68(10):1219-32. Available from: https://doi.org/10.1111/all.12214
2. Ortega N, Doña I, Moreno E, et al. Practical guidelines for diagnosing hypersensitivity reactions to nonsteroidal anti-inflammatory
drugs. J Investig Allergol Clin Immunol. 2014;24(5):308-23. Available from: https://www.jiaci.org/issues/vol24issue5.html
3. Varga C, Pávai Z, Bán EG, Faludi B, Pap Á. The role of cyclooxygenase-2 in ulcer healing. Curr Pharm Des. 2003;9(27):2241-52.
Available from: https://doi.org/10.2174/1381612033453674
4. Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J
Pharm Pharm Sci. 2008;11(2):81s-110s. Available from: https://doi.org/10.18433/j34g6z
5. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):986-1000. Available
from: https://doi.org/10.1161/ATVBAHA.110.207449
6. Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and
coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2010;24(2):121-32. Available from: https://doi.org/10.1016/j.bpg.2010.01.001
7. Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal anti-inflammatory drugs: an update of gastrointestinal,
cardiovascular and renal complications. J Pharm Pharm Sci. 2013;16(5):821-47. Available from: https://doi.org/10.18433/j3hq4d
8. Kidon M, Blanca-Lopez N, Gomes E, et al. EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions
to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents. Pediatr Allergy Immunol. 2018;29(5):469-80.
Available from: https://doi.org/10.1111/pai.12906
9. Angeletti F, Meier K, Zöller E, Meiss F, Hügel R, Vach W. Hypersensitivity reactions to non-steroidal anti-inflammatory drugs
(NSAIDs) - a retrospective study. J Dtsch Dermatol Ges. 2020;18(12):1405-14. Available from: https://doi.org/10.1111/ddg.14246
10. Doña I, Barrionuevo E, Blanca-López N, et al. Trends in hypersensitivity drug reactions: more drugs, more response patterns,
more heterogeneity. J Investig Allergol Clin Immunol. 2014;24(3):143-53. Available from: https://www.jiaci.org/issues/vol24issue3.html
11. Nissen CV, Bindslev-Jensen C, Mortz CG. Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs): classification
of a Danish patient cohort according to EAACI/ENDA guidelines. Clin Transl Allergy. 2015;5:10. Available from: https://doi.org/10.1186/s13601-015-0058-8